News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
373,748 Results
Type
Article (16033)
Company Profile (117)
Press Release (357598)
Multimedia
Podcasts (49)
Webinars (7)
Section
Business (114682)
Career Advice (522)
Deals (19019)
Drug Delivery (38)
Drug Development (32168)
Employer Resources (60)
FDA (8977)
Job Trends (7962)
News (176420)
Policy (12892)
Tag
2024 BioCapital Digital (1)
2024 BioForest Digital (6)
2024 BioMidwest Digital (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (8)
2024 Biotech Beach Digital (2)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (1)
2024 Genetown Standard (5)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (3)
2024 Pharm Country Standard (1)
2025 Lone Star Bio Digital (3)
2026 BioCapital Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Standard (1)
2026 Genetown Elite (1)
2026 Genetown Standard (1)
2026 Pharm Country Standard (2)
Academia (1405)
Accelerated approval (3)
Adcomms (1)
Allergies (43)
Alliances (35225)
ALS (31)
Alzheimer's disease (546)
Antibody-drug conjugate (ADC) (78)
Approvals (9007)
Artificial intelligence (244)
Autoimmune disease (6)
Automation (13)
Bankruptcy (136)
Best Places to Work (6737)
BIOSECURE Act (8)
Biosimilars (11)
Biotechnology (89)
Bladder cancer (31)
Brain cancer (14)
Breast cancer (123)
Cancer (1092)
Cardiovascular disease (71)
Career advice (457)
Career pathing (9)
CAR-T (108)
Cell therapy (287)
Cervical cancer (11)
Clinical research (25219)
Collaboration (620)
Compensation (118)
Complete response letters (4)
COVID-19 (1190)
CRISPR (40)
C-suite (153)
Cystic fibrosis (47)
Data (1050)
Decentralized trials (1)
Denatured (20)
Depression (17)
Diabetes (110)
Diagnostics (4982)
Digital health (16)
Diversity (6)
Diversity, equity & inclusion (11)
Drug discovery (79)
Drug pricing (20)
Drug shortages (4)
Duchenne muscular dystrophy (30)
Earnings (39244)
Editorial (6)
Employer branding (12)
Employer resources (52)
Events (52726)
Executive appointments (417)
FDA (9643)
Featured Employer (26)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (1)
Funding (502)
Gene editing (94)
Generative AI (24)
Gene therapy (203)
GLP-1 (249)
Government (1386)
Grass and pollen (2)
Guidances (28)
Healthcare (10404)
Huntington's disease (5)
IgA nephropathy (12)
Immunology and inflammation (35)
Indications (14)
Infectious disease (1268)
Inflammatory bowel disease (66)
Inflation Reduction Act (4)
Influenza (34)
Intellectual property (64)
Interviews (62)
IPO (8207)
IRA (10)
Job creations (1509)
Job search strategy (403)
Kidney cancer (4)
Labor market (10)
Layoffs (129)
Leadership (3)
Legal (2644)
Liver cancer (39)
Lung cancer (133)
Lymphoma (67)
Machine learning (5)
Management (19)
Manufacturing (193)
MASH (19)
Medical device (11571)
Medtech (11576)
Mergers & acquisitions (11172)
Metabolic disorders (232)
Multiple sclerosis (30)
NASH (3)
Neurodegenerative disease (35)
Neuropsychiatric disorders (5)
Neuroscience (760)
NextGen: Class of 2025 (3726)
Non-profit (1732)
Northern California (1177)
Now hiring (10)
Obesity (96)
Opinion (92)
Ovarian cancer (42)
Pain (54)
Pancreatic cancer (43)
Parkinson's disease (69)
Partnered (12)
Patents (150)
Patient recruitment (57)
Peanut (26)
People (33638)
Pharmaceutical (16)
Pharmacy benefit managers (2)
Phase I (9316)
Phase II (11348)
Phase III (7490)
Pipeline (583)
Policy (36)
Postmarket research (526)
Preclinical (4186)
Press Release (66)
Prostate cancer (47)
Psychedelics (4)
Radiopharmaceuticals (159)
Rare diseases (164)
Real estate (3430)
Recruiting (25)
Regulatory (9698)
Reports (18)
Research institute (1330)
Resumes & cover letters (82)
Rett syndrome (4)
RNA editing (2)
RSV (23)
Schizophrenia (16)
Series A (90)
Series B (58)
Service/supplier (7)
Sickle cell disease (32)
Southern California (1234)
Special edition (2)
Spinal muscular atrophy (63)
Sponsored (15)
Startups (2571)
State (2)
Stomach cancer (3)
Supply chain (27)
Tariffs (7)
The Weekly (28)
United States (11948)
Vaccines (333)
Venture capitalists (20)
Weight loss (41)
Women's health (18)
Worklife (3)
Date
Today (82)
Last 7 days (436)
Last 30 days (1401)
Last 365 days (17574)
2025 (5600)
2024 (19052)
2023 (22518)
2022 (31326)
2021 (33098)
2020 (31289)
2019 (26869)
2018 (20161)
2017 (19302)
2016 (18226)
2015 (21083)
2014 (15505)
2013 (12998)
2012 (14053)
2011 (14347)
2010 (13027)
Location
Africa (328)
Alabama (41)
Alaska (6)
Arizona (125)
Arkansas (10)
Asia (24364)
Australia (4267)
California (3051)
Canada (1067)
China (257)
Colorado (172)
Connecticut (129)
Delaware (47)
Europe (50195)
Florida (492)
Georgia (140)
Idaho (33)
Illinois (301)
India (14)
Indiana (164)
Iowa (5)
Japan (115)
Kansas (83)
Kentucky (6)
Louisiana (6)
Maine (20)
Maryland (465)
Massachusetts (2101)
Michigan (185)
Minnesota (254)
Mississippi (2)
Missouri (62)
Montana (24)
Nebraska (15)
Nevada (23)
New Hampshire (67)
New Jersey (928)
New Mexico (16)
New York (888)
North Carolina (535)
North Dakota (8)
Northern California (1177)
Ohio (109)
Oklahoma (11)
Oregon (20)
Pennsylvania (614)
Puerto Rico (10)
Rhode Island (25)
South America (532)
South Carolina (20)
South Dakota (1)
Southern California (1234)
Tennessee (63)
Texas (481)
Utah (110)
Virginia (59)
Washington D.C. (13)
Washington State (343)
West Virginia (3)
Wisconsin (39)
373,748 Results for "blue spark technologies".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Layoffs
Spark Therapeutics Cuts 298 Employees as Part of Reorganization
Roche’s reorganization of Spark Therapeutics is coming more into focus, with nearly 300 employees being let go by the end of this year. Spark also trimmed its staff in 2024.
April 4, 2025
·
1 min read
·
Angela Gabriel
Gene therapy
Roche Absorbs $2.4B Impairment in Overhaul of Spark Gene Therapy Unit
Roche acquired Spark Therapeutics in 2019 for $4.8 billion.
March 11, 2025
·
2 min read
·
Tristan Manalac
Tariffs
Trump Tariff Pause Sparks Late-Day Rally for Pharma Stocks—But Not All
Pharma stocks went on a wild ride Wednesday amid whiplashing tariff threats from the U.S. president.
April 10, 2025
·
2 min read
·
Annalee Armstrong
BioMidwest
Blue Spark Technologies to Highlight Continuous Patient Temperature Monitoring at CES 2023
Blue Spark Technologies, Inc., a leader in wearable remote patient monitoring solutions, will showcase TempTraq® at the 2023 Consumer Electronics Show at the Las Vegas Convention Center January 5-8.
January 3, 2023
·
3 min read
Press Releases
electroCore, Inc. Announces Agreement with Spark Biomedical Inc. to Distribute Sparrow Ascent for Opioid Withdrawal
February 27, 2025
·
4 min read
Business
SHINE Technologies Partners with Blue Earth Therapeutics for First Supply of Ilumira from Its New Facility
SHINE Technologies, LLC (SHINE), a pioneer in next-generation fusion-based technology, today announced a new partnership with Blue Earth Therapeutics, a Bracco company and recognized leader in the development of innovative radiopharmaceuticals.
June 6, 2024
·
3 min read
Press Releases
ILM-Blue from DORC Receives NMPA Approval in China; Expanding Global Reach
March 27, 2025
·
5 min read
Press Releases
SPARK NS Selects Eight Projects to Receive Aggregate Funding of Up to $16 Million to Advance Academic Discoveries in Parkinson’s Disease from the Lab to the Clinic
April 4, 2025
·
5 min read
Press Releases
Blue Earth Therapeutics initiates Phase 2 Clinical Trial evaluating the efficacy and safety of Lutetium (177Lu) rhPSMA-10.1 Injection in metastatic castrate resistant prostate cancer
May 1, 2025
·
5 min read
FDA
Blue Arbor Technologies Receives FDA Breakthrough Device Designation and TAP Enrollment for the RESTORE™ Neuromuscular Interface System
Blue Arbor Technologies Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to the RESTORE™ Neuromuscular Interface System for people with upper limb loss.
April 24, 2024
·
6 min read
1 of 37,375
Next
